ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2013

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes.

Miyako KishimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.